Ittichaicharoen, J., Phrommintikul, A., Chattipakorn, N., & Chattipakorn, S. (2018). Reduced salivary amylase activity in metabolic syndrome patients with obesity could be improved by treatment with a dipeptidyl peptidase IV inhibitor.
استشهاد بنمط شيكاغوIttichaicharoen, Jitjiroj, Arintaya Phrommintikul, Nipon Chattipakorn, و Siriporn Chattipakorn. Reduced Salivary Amylase Activity in Metabolic Syndrome Patients With Obesity Could Be Improved By Treatment With a Dipeptidyl Peptidase IV Inhibitor. 2018.
MLA استشهادIttichaicharoen, Jitjiroj, Arintaya Phrommintikul, Nipon Chattipakorn, و Siriporn Chattipakorn. Reduced Salivary Amylase Activity in Metabolic Syndrome Patients With Obesity Could Be Improved By Treatment With a Dipeptidyl Peptidase IV Inhibitor. 2018.